Studies suggested that circulating IL-6 and CRP may serve as powerful biomarkers for a poor prognosis in glioma patients.19,20 Further results showed that microsurgical treatment for glioma can improve cognitive function and ADL. The gene discussed is IL6; the disease is central nervous system cancer.